Ets Medical De La Teppe
- Address
- 25 Avenue De La Bouterne, Cs 9721, 26600, France
Neurology – Drug‑Resistant Focal Cortical Dysplasia
The department focuses on nervous system diseases, specifically studying patients with drug‑resistant seizures associated to focal cortical dysplasia. Trials aim to evaluate the safety and tolerability of a new adjunctive therapy.
- Assessment of safety and tolerability in a real‑world setting
- Evaluation of drug‑drug interactions for the investigational compound
- Monitoring long‑term tolerability in adolescents and adults
At Ets Medical De La Teppe, researchers are working to improve treatment options for individuals whose seizures remain uncontrolled despite existing medications.
Neurology – Adjunctive Therapy Development
This research explores the use of PTI5803 as an adjunctive therapy for drug‑resistant focal epilepsy, aiming to gather early signals of efficacy while characterizing pharmacokinetic and pharmacodynamic profiles.
- Dose‑escalation regimen to determine optimal exposure
- Pharmacokinetic and pharmacodynamic profiling in patients ≥ 14 years
- Observation of initial efficacy indicators during the open‑label phase
The hospital‑based program provides a pathway for patients to access innovative treatments while contributing valuable data to the field of epilepsy research.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1PannTheraPi2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1PannTheraPi2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ets Medical De La Teppe
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long‑Term Safety and Tolerability of Probenecid (PTI5803) as Adjunctive Therapy in Patients ≥ 14 Years with Drug‑Resistant Focal Epilepsy due to Focal Cortical Dysplasia | PannTheraPi | Phase II | Not Yet Recruiting | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.